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Abstract
Background: Nesfatin-1 is a recently discovered anorexigen encoded in the precursor peptide, nucleobindin-2 (NUCB2) in
mammals. To date, nesfatin-1 has not been described in any non-mammalian species, although some information is
available in the sequenced genomes of several species. Our objective was to characterize nesfatin-1 in fish.
Methodology/Principal Findings: In the present study, we employed molecular, immunohistochemical, and physiological
studies to characterize the structure, distribution, and appetite regulatory effects of nesfatin-1 in a non-mammalian
vertebrate. A very high conservation in NUCB2 sequences, especially in the nesfatin-1 region was found in lower vertebrates.
Abundant expression of NUCB2 mRNA was detected in several tissues including the brain and liver of goldfish. Nesfatin-1-
like immunoreactive cells are present in the feeding regulatory nucleus of the hypothalamus and in the gastrointestinal tract
of goldfish. Approximately 6-fold increase in NUCB2 mRNA levels was found in the liver after 7-day food-deprivation, and a
similar increase was also found after short-term fasting. This points toward a possible liver specific role for NUCB2 in the
control of metabolism during food-deprivation. Meanwhile, ,2-fold increase at 1 and 3 h post-feeding and an ,3-fold
reduction after a 7-day food-deprivation was observed in NUCB2 mRNA in the goldfish hypothalamus. In vivo, a single
intraperitoneal injection of the full-length native (goldfish; gf) nesfatin-1 at a dose of 50 ng/g body weight induced a 23%
reduction of food intake one hour post-injection in goldfish. Furthermore, intracerebroventricular injection of gfnesfatin-1 at
a dose of 5 ng/g body weight resulted in ,50% reduction in food intake.
Conclusions/Significance: Our results provide molecular, anatomical and functional evidences to support potential
anorectic and metabolic roles for endogenous nesfatin-1 in goldfish. Collectively, we provide novel information on NUCB2
in non-mammals and an anorexigenic role for nesfatin-1 in goldfish.
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Introduction
Nesfatin-1 is a recently identified anorectic peptide cleaved from
the N-terminal of the precursor protein nucleobindin 2 (NUCB2)
[1]. Nesfatin-1 immunoreactivity (ir) has been detected in
mammalian brain regions that regulate feeding and metabolism
[1–8] and peripherally in the endocrine cells of the stomach,
pituitary [9] and pancreas [9–11]. In addition, nesfatin-1 has been
detected in both rat cerebrospinal fluid [1] and in the peripheral
circulation of humans and rodents [9,12–14]. Several reports
provide clear evidence in support of an inhibitory role for nesfatin-
1 on food intake and body weight [1,13–15]. Acute administration
of nesfatin-1, by central or peripheral injections has been shown to
reduce food intake in rats for up to 6 hours [1,13–15]. In addition,
prolonged continuous central infusion of nesfatin-1 reduces
subcutaneous, mesenteric and epididymal fat mass [1]. In addition
to this, nesfatin-1 has been shown to regulate cardiac functions
[16], reduce blood glucose levels in diabetic mice [14], and induce
fear and anxiety like behaviors [17]. Thus, nesfatin-1 is emerging
as a multifunctional peptide with predominant anorectic effects in
mammals.
Oh-I et al. (2006) initially proposed the post-translational
processing of NUCB2 (pronesfatin) by prohormone convertases
(PCs) through specific cleavage sites. These cleavage sites which
consist of the basic amino acid pairs, Lys-Arg and/or Arg-Arg
remain conserved in goldfish. It is well known that PC1/3 and
PC2 are the major PCs involved in prohormone processing. In
addition, previous studies have described the presence of PC1/3
and PC2 in early evolution [18] including in fish [19,20]. Thus, if
we infer that PCs perform a similar function in non-mammalian
vertebrates the processing of pronesfatin by PCs may yield nesfatin
1, nesfatin-2, and nesfatin-3, as proposed in mammals. According
to Shimizu et al., (2009) the mid-segment of nesfatin-1 (24–53
amino acids) is the active appetite inhibitory segment, as
intraperitoneal injections of the c- (1–23) and n-terminals (54–
82) of nesfatin-1 had no anorectic effects in mammals. While the
physiological roles of nesfatin-1 in mammals are being character-
ized, the existence and functions of NUCB2 and encoded peptides
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esized that NUCB2 is present in lower vertebrates and nesfatin-1
has appetite regulatory effects in fish. The objectives of this study
were to identify NUCB2 sequences in lower vertebrates, and to
characterize the appetite regulatory effects of nesfatin-1 in goldfish,
a very well characterized and widely used organism for studying
feeding regulatory peptides. We identified NUCB2 mRNA
sequences from many lower vertebrates, and further characterized
the appetite regulatory role of this peptide using goldfish. Both
NUCB2 mRNA and nesfatin-1-like ir was found in the appetite
regulatory regions of the brain and also in several peripheral
tissues of fish. Food deprivation caused a significant reduction in
hypothalamic NUCB2 mRNA expression. Acute central or
peripheral injections of the synthetic form of native nesfatin-1
inhibits food intake in goldfish. Collectively, these results provide
novel evidences for an evolutionarily conserved structure and
biological action for nesfatin-1 in fish.
Materials and Methods
Ethics Statement
All experimental protocols using fish were approved by the York
University Animal Care Committee, and strictly adhered to the
policies of the Canadian Council for Animal Care.
Animals
Male and female goldfish (Carassius auratus; common variety) (3–
4 inches long and 20–30 g body weight) were purchased from local
suppliers and maintained at 20 C water temperature under a
simulated natural photoperiod (10 h light:14 h dark). All fish were
fed commercial pellet diet (Martin Profishent, Ontario, Canada)
once a day at 12:00 PM to satiety. For all feeding studies, food
intake was monitored daily during the 2-week acclimation period.
Fish were anesthetized in 0.015% tricainemethane sulfonate
(Syndel Laboratories, Vancouver, Canada) before intracerebro-
ventricular (ICV), intraperitoneal (IP) injections and dissection of
tissues for total RNA extraction.
Materials
Goldfish nesfatin-1 (1–82) (gfnesfatin-1; VPISIDKTKVKL-
PEETVKES PQNVDTGLHYDRYLREVIDFLEKDQHFREK-
LHNTDMEDIKQGKLAKELDFVSHHVRTKLDEL) was cus-
tom synthesized by Genscript (Piscataway, NJ). The purity of the
peptide was confirmed by using HPLC, Electrospray Ionization
Mass Spectrometry and MALDI-TOF. The peptide was synthe-
sized with 98% purity, with a single peak confirming the predicted
mass. Peptide aliquots were always freshly reconstituted in fish
physiological saline [21] prior to use.
Identification and phylogenetic analysis of non-
mammalian NUCB2 sequences
NUCB2 gene/mRNA and protein sequencing information for
zebrafish (Danio rerio), Western clawed frog (Xenopus tropicalis),
chicken (Gallus gallus), mouse (Mus musculus) and human (Homo
sapiens) were obtained from annotated sequences available through
the GenBank (http://www.ncbi.nlm.nih.gov/genbank/) and the
Ensembl genome databases (http://www.ensembl.org/index.
html). With the exception of zebrafish, all other teleost NUCB2
sequences have not yet been annotated. In addition, two
paralogous zebrafish NUCB2 genes, NUCB2A and NUCB2B,
exist due to the teleost-specific whole-genome duplication. We
compiled all other teleost NUCB2 sequences from the Ensembl
genome databases using the zebrafish NUCB2A and NUCB2B
protein sequences as the in silico probes. We aligned similar
sequences which most highly match with those two paralogous
NUCB2 in zebrafish within the genomes of stickleback (Gasterosteus
aculeatus), medaka (Oryzias latipes), green pufferfish (Tetraodon
nigroviridis) and fugu (Takifugu rubripes). In addition, NUCB1
sequences were available for many species within Genbank and
Ensembl databases. The NUCB1 and NUCB2 sequences obtained
were aligned using ClustalW2 general purpose multiple sequence
alignment program for DNA or protein [22]. A phylogenetic
analysis based on the amino acid sequences was constructed using
the freeware ‘‘Phylogeny.fr’’ (http://www.phylogeny.fr/) [23].
Determination of goldfish NUCB2 mRNA
Total RNA was extracted from goldfish brain using the
TRIzolH RNA isolation reagent (Invitrogen, Canada). RNA purity
was checked by optical density (OD) absorption ratio (OD
260 nm/OD 280 nm) using a MultiskanH Spectrum spectropho-
tometer (Thermo, Vantaa, Finland). Only samples with an
absorption ratio .1.7 were used for cDNA synthesis. Synthesis
of cDNAs was conducted using iScript
TM cDNA synthesis kit as
directed by the manufacturer (BioRad, Canada). The cDNAs were
used as templates for reverse transcription-PCR (RT-PCR) with
two primers based on the zebrafish NUCB2 mRNA sequences
available on Genbank (NM_201493): gfNes-1F and gfNes-1R
(Table S1). The subsequent partial amplification (885 bp) of
goldfish NUCB2 cDNA was gel extracted and purified using a
QIAquick Spin kit (QIAGEN, Canada). To obtain the full-length
NUCB2 cDNA sequence, the partial NUCB2 cDNA was
extended using 39 and 59 rapid amplification of cDNA ends as
directed by the manufacturer of the 39 and 59 RACE kits
(Invitrogen, Canada). The following gene specific primers were
used for 39RACE: gfNes-3 1FP and gfNes-3 2FP, and for
59RACE: gfNes-5 GSP1 and gfNes-5 GSP2 (Table S1).
Tissue Distribution of NUCB2 mRNA in Goldfish
The following tissues were collected from goldfish: hindbrain,
midbrain, hypothalamus, telencephalon, olfactory bulbs, pituitary,
anterior intestine (J-loop), posterior intestine (rectum), kidney,
spleen, liver, heart, eye, muscle, gill, gall bladder, adipose, ovary,
testes, and skin. Total RNA was extracted and cDNA was
synthesized as described above. Quantification was conducted
using species-specific primers for NUCB2A, gfNes-qRTF2, gfNes-
qRTR1 (Table S1). The gene specific primers amplified a 196 bp
region within the nesfatin-1 encoding region. The amplicons
spanned exons 3–5 serving as a control for genomic contamina-
tion. Based on the zebrafish paralogous NUCB2 sequences, exon 2
for NUCB2A is 20 base pairs larger than exon 2 in NUCB2B. In
addition, the template products were validated by DNA
sequencing performed with the Applied Biosystems DNA
Sequencer (3130xL) using the BigDyeH Terminator chemistry
and showed the highest similarity to zebrafish NUCB2A in a
BLAST search. Furthermore, subsamples of all real-time quanti-
tative reverse transcription PCR (qRT-PCR) products were
electrophoresed to confirm the amplicon size. No double band
was observed suggesting the paralogous NUCB2B gene was not
amplified. Species-specific b-actin primers served as internal
controls to normalize cDNA quantity for each tissue sample.
Quantification, using qRT-PCR, of NUCB2 and b-actin mRNA
was performed in triplicate on all samples using an iQ
TM SYBRH
Green Supermix on a Chromo4
TM Multicolor Real-Time PCR
Detection System (Bio-Rad, Canada). Thermal cycling was
conducted as follows: 3 minutes at 95uC, then 40 cycles were
performed with 95uC denaturation step for 30 seconds, an
annealing temperature of 59uC for 30 s and an extension
temperature of 73uC for 30 min. To confirm the efficiency of
Nesfatin-1 Inhibits Feeding in Fish
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of a standard curve and calculations of amplification efficiency
were conducted for each qRT-PCR assay. The efficiency (E)o f
PCR was calculated from the regression slope of the assay (E=
10
-1/slope). REST-MCS
 version 2 software was used to analyze the
data. Relative expression data was obtained after normalization
of NUCB2 mRNA expression in each sample using b-actin
expression from the same sample. Data were normalized
according to the Pfaffl method [24]. Purity of each amplicon
was confirmed by a melting curve, which consisted of a slow ramp
from 55 C to 95 C with SYBR Green readings taken every 1 C for
40 cycles.
Periprandial Expression of NUCB2 mRNA in Goldfish
Hypothalamus and Liver
In all vertebrates the hypothalamus, adipose tissue, and liver are
major regulators of food intake and energy homeostasis. In this
study, we examined periprandial (pre- and post-feeding) changes
of NUCB2 mRNA expression in the hypothalamus and liver, two
tissues that show abundant expression of NUCB2. Seven groups of
weight-matched goldfish (n=6/group) were acclimated for 2 weeks
to tank conditions and fed daily at a scheduled time (12:00, 0 h) for
2 weeks. Hypothalamus and liver samples were collected at: 3 h
prior to feeding (23 h), 1 h prior to feeding (21 h), upon
commencement of feeding (0 h), 1 h after feeding (+1h )a n d3h
after feeding (+3 h). Two unfed groups were sampled at +1 h, and
+3 h and served as the unfed group. Total RNA extraction, cDNA
synthesis, and qRT-PCR were conducted as described above. The
NUCB2 mRNA is expressed as a percentage of the normalized
NUCB2 expression at 23h .
Food Deprivation Induced Changes in NUCB2 mRNA
Expression in Goldfish Hypothalamus and Liver
The homeostatic alterations induced by food deprivation can
change the expression of appetite regulatory peptides within the
neuroendocrine system [25]. This study examined the changes in
NUCB2 mRNA expression in the hypothalamus and liver of
goldfish during food deprivation over a seven-day period. Five
groups of weight-matched goldfish (n=6/group) were acclimated to
tank conditions and fed daily at a scheduled time for 2 weeks. Two
groups of fish were then not fed or exposed to food for 3 or 7 days,
while the two control groups were fed daily. Hypothalamus and
liver were sampled on days 3 and 7 from the fasted fish, and from
the fed fish at 3 h post-feeding. After a 7 day fast, one additional
unfed group was re-fed and sampled at 3 h post-re-feeding. Tissue
extraction and relative gene expression quantification were
conducted as described previously.
Effects of the Feeding Status on Serum Nesfatin-1 Levels
in Goldfish
If nesfatin-1 indeed is an endogenous anorexigen, we expect to
see an association between the nutritional status of the animal and
changes in circulating nesfatin-1 levels. To investigate meal related
changes in nesfatin-1 levels, serum samples were collected from ad
libitum fed, 1 and 3 hour post-fed, as well as 24 h fasted goldfish
(n=5/group). Blood samples were collected from the caudal vein
and serum was collected immediately by centrifugation (7000 rpm
for 9 minutes at 4 C) and stored at 220 C. Serum nesfatin-1 levels
were measured using the Nesfatin-1 (1–82) (Rat) ELISA kit (Cat.
No. EK-003-2, Phoenix Pharmaceuticals Inc., CA). This assay was
validated for use in fish and the quality controls provided with the
kit were within the expected range. To confirm the efficiency of
the ELISA with synthetic goldfish nesfatin-1, a standard curve was
plotted from the absorbance and logarithmic values for the
different amounts of peptide. The amount of immunoreactive
material was determined using a non-linear regression curve-fit,
which was used to quantify the concentration of nesfatin-1 in
serum samples.
Western Blot Analysis
Brain samples were harvested from goldfish and Fischer 344 rats
(for positive control) and sonicated for 30 seconds on ice in Lysis
Buffer (135 mM NaCl, 1 mM MgCl, 2.7 mM KCl, 20 mM Tris
buffer pH 8, 1% Triton-X, 10% Glycerol, 0.5 mM Sodium
vanadate, 0.2 mM phenylmethanesulfonylfluoride, 10 mM NaF).
The whole tissue protein lysates were centrifuged at 12,000 rpm
for 20 minutes at 4 C to remove cellular debris. The supernatant
was used as the soluble protein extract. Final protein concentra-
tions were determined by Bio-Rad Protein Assay (Bio-Rad,
Hercules, CA). Gel samples were prepared by mixing the protein
samples with gel loading buffer (4% SDS, 0.05% bromophenol
blue (w/v), 20% glycerol, 1% mercaptoethanol (v/v) in 0.1 M Tris
buffer, pH 6.8). Samples were incubated at 100 C for 5 minutes.
They were subsequently loaded on a 10% SDS-polyacrylamide
gel. After SDS-PAGE, proteins were transferred to a nitrocellulose
membrane (Pall, Mexico) for 2 h at 4 C. The membrane was
blocked in Tris-buffered saline [TBS; 10 mM Tris, 150 mM
NaCl, 0.05% Tween, v/v] containing 5% (w/v) nonfat milk
(Carnation, Nestle ´, Glendale, CA). After 1 h, the membranes were
incubated in primary antibody (polyclonal anti-nesfatin-1, Phoenix
Pharmaceuticals, Burlingame, CA) diluted 1:1000 in TBS
containing 5% (w/v) non-fat milk overnight. Membranes were
later washed three times with TBS containing 0.5% non-fat milk.
Secondary antibody (anti-rabbit IgG HRP-linked, New England
Biolabs, Pickering, Canada) diluted 1:40,000 in TBS was added to
the membrane. The membrane was subsequently washed twice in
TBS containing 0.5% non-fat milk then twice using TBS only.
Ultimately, the membrane was developed using ECL Western Blot
Substrate (Pierce, Rockford, IL) as per manufacturer’s instructions.
Nesfatin-1-like ir in the Brain and Gut
Goldfish brain and J-loop region (anatomical equivalent of the
mammalian stomach) were dissected under saline and immediately
transferred to 4% paraformaldehyde for a 3 h incubation period (4
C) (n=6 fish). After fixation, tissues were washed with 70%
ethanol, embedded and sectioned sagitally (5 mm thickness).
Sections were deparaffinized with xylene (3610 minutes, 25 C)
and rehydrated in a graded ethanol series. DAKOH serum-free
protein block reagent (DAKO Corporation, CA) was used to block
the section for 10 minutes prior to incubation with rabbit anti-
nesfatin-1 primary antibody (Pheonix Pharmaceuticals; 1:500
dilution) for 18 h at 4 C. After incubation, slides were washed
with 1X PBS (3610 minutes, 25 C) and incubated with goat anti-
rabbit Texas RedH IgG (Red-Nesfatin-1; Vector Laboratories,
CA; 1:1000 dilution) secondary antibody for 1 h at room
temperature. Lastly, slides were washed with 1X PBS (3610
minutes, 25uC) and mounted with VectashieldH mounting
medium containing DAPI (Blue nuclear stain; Vector Laborato-
ries). Negative controls were treated with secondary antibody only.
All images were taken using a Nikon Eclipse Ti-inverted
fluorescence microscope (Nikon Canada, Mississauga, Canada)
connected to a Dell HP Workstation computer and NIS-elements
basic research imaging software (Nikon Canada, Mississauga,
Canada). Representative images were chosen from a large number
of sections assessed from tissues of all six fish. Anatomical
localization and nomenclature were based on the goldfish brain
atlas [26].
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Goldfish
To determine the influence of nesfatin-1 on food intake in
goldfish, gfnesfatin-1 was peripherally administered. Seven groups
of six, weight-matched goldfish (Body Weight [BW]
=36.6167.20 g) were IP injected with 500, 50, 5. 0.5 and 0 ng/
gB Wgfnesfatin-1 (both saline and 50 ng/g BW groups were
repeated IP injections because these studies were conducted on
separate days). Goldfish were allowed to acclimate to tanks over a
period of two weeks prior to the study to reduce the effects of
stress. The fish were fed at a scheduled feeding time (12:00 h) once
a day with 4% BW ration per fish and food intake was measured
daily for 1 h post-feeding. On the day of the study, goldfish were
anesthetized prior to their daily scheduled feeding time and treated
with an injection of either 100 ml saline alone or peptide using a
1 ml syringe and 25
(5/8) G needle (BD, Oakville, Canada).
Subsequently, fish were returned to aquariums and fed at 5
minutes post-injection, at which all fish were active and swimming.
Uneaten food pellets were removed 1 h after feeding, dried for
24 h, and weighed the next day. Quantification of food intake was
determined by subtracting the dry weight of the total amount of
food given by the dry weight of the food removed from the
aquarium after 1 h. All remaining studies were conducted with the
same acclimation and feeding protocols unless otherwise stated.
Effects of ICV Injections of Nesfatin-1 on Food Intake of
Goldfish
The anorectic effect of nesfatin-1 was discovered mainly after
directly administering it into the brain of rodents [1]. We used
ICV injections, a very well characterized technique in goldfish to
test the central effects of nesfatin-1 on feeding. ICV injections were
conducted as previously described [27]. Briefly, three groups of six
weight-matched goldfish (BW =33.7169.71 g) were used for
central injections of 25, 0.5 and 0 ng/g BW gfnesfatin-1.
Subsequently, fish were returned to their respective aquariums
and fed 6% BW ration per fish following a five minute recovery
period. Uneaten food pellets were removed after 1 h and
measured as previously described.
Statistical analysis
Statistical analyses for qRT-PCR, food intake studies and
nesfatin-1 ELISA data were conducted using a one-way ANOVA
followed by Student-Newman-Keuls multiple comparison test
(GraphPad Prism 4, San Diego, CA). Significance was considered
at P,0.05. Data is expressed as mean 6 SEM.
Results
Identification of Teleost NUCB2 Genes and Sequencing of
the Goldfish NUCB2 mRNA
The NUCB2 gene structure is remarkably well conserved
among both teleosts and other vertebrates examined. NUCB2 in
the cyprinids, Carassius auratus (goldfish) and Danio rerio (zebrafish)
most closely aligned together (Figure 1). NUCB2A and
NUCB2B gene sequences in zebrafish consist of 13 exons
interspaced by 12 introns (Figure 1A). The same gene
organization is found in Oryzias latipes (medaka) and Gasterosteus
aculeatus (stickleback). NUCB2A in Takifugu rubripes (fugu) and
Tetraodon nigroviridis (green pufferfish) both have 12 exons
interspaced by 11 introns and this appears to be due to the
deletion of exon 1. (Figure 1A). Goldfish NUCB2 mRNA was
amplified from the brain and sequenced (Figure S1; GenBank
accession number: HM065567). The deduced NUCB2 protein is
composed of 499 amino acid residues, with a 23 amino acid signal
region and a 476 amino acid protein (Figure S1). In addition, the
proposed prohormone convertase cleavage site (Lys-Arg) is
ubiquitously conserved (Figure 1B). The nesfatin-1 region in
the goldfish NUCB2A sequence has high percent similarity to the
nesfatin-1 region of NUCB2 or NUCB2A (teleost only) of other
species including: zebrafish (Danio rerio; 94%), medaka (Oryzias
latipes; 91%), stickleback (Gasterosteus aculeatus; 86%), green
pufferfish (Tetraodon nigroviridis; 84%), fugu (Takifugu rubripes;
83%), Western clawed frog (Xenopus tropicalis; 64%), chicken
(Gallus gallus; 66%) mouse (Mus musculus; 57%), and human (Homo
sapiens; 63%) (Figure 1B). The nesfatin-1 region of the NUCB1
sequences share the lowest similarity to NUCB2 in the N-terminal
of the peptide (Figure 1C). Interestingly, much of the C-terminal
region of the putative nesfatin-1 sequence are highly conserved
including the proposed prohormone convertase cleavage site. To
date, there have been no reports on the processing of nesfatin-1
from NUCB1 or any reports of the involvement of NUCB1 in
food intake or glucose homeostasis.
Sequences were obtained from the Ensembl database and
GenBank and were aligned using ClustalW. Ensembl database
accession numbers of the sequences were as follows; Gasterosteus
aculeatus (NUCB1, ENSGACP00000016912; NUCB2A, EN-
SGACP00000020611; NUCB2B, ENSGACP00000008999), Or-
yzias latipes (NUCB2A, ENSORLP00000008372; NUCB2B, EN-
SORLP00000001612), Tetraodon nigroviridis (NUCB2A, ENSTNIP-
00000012254; NUCB2B, ENSTNIP00000005671), Takifugu ru-
bripes (NUCB1, ENSTRUP00000000823; NUCB2A, ENSTR-
UP00000044315; NUCB2B, ENSTRUP00000038477). GenBank
accession numbers of the sequences were as follows; Carassius
auratus (NUCB2A, HM065567.1), Danio rerio (NUCB1, NM_
001045463.1; NUCB2A, NM_201493.1; NUCB2B, NM_201479.1),
Xenopus tropicalis, (NUCB2, AAH90107.1), Gallus gallus (NUCB2,
NP_001006468.1), Mus musculus (NUCB1, AAH72554.1; NUCB2,
AAH10459.1) and Homo sapiens (NUCB1, NP_006175.2; NUCB2,
NP_005004.1).
In the phylogenetic analysis (Figure 2), the amino acid
sequence of goldfish NUCB2A was clustered with the NUCB2A
sequences of other teleostean fishes, while most strongly clustering
with zebrafish NUCB2A. In addition, the teleostean NUCB2B
sequences were divided from the NUCB2A sequences, although
zebrafish NUCB2B is more closely grouped with NUCB2A than
with other NUCB2B sequences. NUCB1, NUCB2, and the
teleostean NUCB2 paralogous were all divided from mammalian,
amphibian, avian and invertebrate homologues with high
bootstrap value.
Tissue Distribution of NUCB2 mRNA in Goldfish
In goldfish, reverse transcriptase PCR detected abundant
NUCB2 mRNA expression in the liver and pituitary in addition
to various regions of the brain, including the olfactory bulbs,
hypothalamus,telencephalon,midbrainandhindbrain(Figure3A).
More quantitative measurements were made by qRT-PCR.
Relative to the liver, lower levels of NUCB2 mRNA expression
was detected in the adipose tissue, ovary, eye, kidney, and midgut
(Figure 3B). While the lowest levels of NUCB2 mRNA expression
were found in the muscle and gill (Figure 3B).
Periprandial Expression of NUCB2 mRNA in the Goldfish
Hypothalamus and Liver
There was an ,2-fold increase in NUCB2 mRNA expression in
the hypothalamus of fed goldfish at 1 and 3 h post-feeding
compared to unfed controls (P,0.001, one-way ANOVA)
(Figure 4A). Interestingly, there was an ,5 and 6-fold increase
Nesfatin-1 Inhibits Feeding in Fish
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animals at 1 and 3 h post-feeding compared to fed controls,
respectively (P,0.05, P,0.001) (Figure 4B). No changes in
NUCB2 mRNA were detected in unfed groups before the
scheduled feeding time and in fed animals after the scheduled
feeding time (Figure 4B). A single melting peak was detected by
melting temperature analyses for both b-actin and NUCB2
mRNA indicative of the specificity of the reaction (data not
shown).
Food Deprivation Induced Changes in NUCB2 mRNA
Expression in Goldfish Hypothalamus and Liver
NUCB2 mRNA expression in the hypothalamus of goldfish fed
daily was ,3 and 2-fold higher compared to fish deprived of food
for 3 or 7 days, respectively (P,0.05, one-way ANOVA)
(Figure 4C). When 7 day food-deprived fish were re-fed, NUCB2
mRNA expression in the hypothalamus increased 2-fold above
that of the 7 day fasted fish (P,0.05, one-way ANOVA)
(Figure 4C). Similar to the unfed fish in the periprandial study,
Figure 1. A figure showing the putative processing of NUCB2 and comparison of nesfatin-1 sequences. Schematic outline of zebrafish
NUCB2 gene and the formation of nesfatin-1 (A). In this figure, the boxes which make up the NUCB2 gene represent exons 1–13 and interspaced lines
represent introns 1–12. The proposed scheme for NUCB2 prepropeptide and putative cleavage sites from the NUCB2 gene are shown. All other
teleosts examined have similar, highly conserved intron:exon organization for the NUCB2A gene, except for pufferfish (Tetraodon nigroviridis) and
fugu (Takifugu rubripes) which have exon 1 deleted. Figure 1B shows the amino acid sequence alignment of the nesfatin-1 region of NUCB2,
NUCB2A and NUCB2B (teleost only). Figure 1C is the alignment of NUCB1 from cartilaginous fish, bony fish, amphibians, birds and mammals. The
name of the species is given on the left side of the alignment and the number of amino acids in the peptide is provided above the alignment. The
colored amino acids highlight the differences in conservation of the amino acids between species within the nesfatin-1 region of NUCB2 and NUCB1.
In addition, the putative cleavage sites are shown in the box. Species names used in the alignment were as follows: zebrafish (Danio rerio), stickleback
(Gasterosteus aculeatus), medaka (Oryzias latipes), green pufferfish (Tetraodon nigroviridis), fugu (Takifugu rubripes), Western clawed frog (Xenopus
tropicalis), chicken (Gallus gallus), mouse (Mus musculus), and human (Homo sapiens).
doi:10.1371/journal.pone.0015201.g001
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in food-deprived fish (Figure 4D). A 4.8-fold and 6.5-fold increase
in NUCB2 mRNA expression was detected in the liver of fish that
were food deprived for 3 and 7 days, respectively. Re-feeding after
a 7-day food-deprivation brought the NUCB2 mRNA to control
levels 3 h post-feeding. No significant changes in NUCB2 mRNA
levels were observed between 3 and 7 day food-deprived groups.
All groups are expressed relative to the level of NUCB2 mRNA
expression of the 3 day fed group (Figure 4C–D).
Effects of Feeding Status on Serum Nesfatin-1 Levels
Food-deprived goldfish had significantly less nesfatin-1 in serum
than regularly fed controls with 2.5260.26 and 6.4563.31 ng/ml,
respectively (P,0.05) (Figure 5A). In addition, serum nesfatin-1
levels remained significantly elevated in circulation (5.9762.19 ng/
ml) up to 1 hr after feeding (P,0.05) (Figure 5A). A standard curve
was plotted from premeasured amounts of the synthetic gfnesfatin-1
and the amount of immunoreactive material was calculated from a
non-linear regression curve-fit of the standard curve (Figure 5B).
The ELISA for goldfish nesfatin-1 is sensitive over a range of 1–
20 ng/ml. The EC50 for the goldfish nesfatin-1 standard curve was
found to be approximately 4.9 ng/ml. It is concluded from the
standard curve that the antiserum is at least 1-order of magnitude
more sensitive to rat nesfatin-1 than to the goldfish nesfatin-1
peptide (Figure 5B). In order to confirm specificity of the anti-
nesfatin-1 antibody, which probes nesfatin-1 and the precursor
NUCB2, a western blot of goldfish whole brain tissue lysates was
conducted. Due to the differences in amino acids constituting the
peptides, rat NUCB2 is expected to be ,50 kDa, while the goldfish
NUCB2 is ,59 kDa. As expected, the antibody targeted full-length
NUCB2 in rat and goldfish brain samples (Figure 5C). No band
representing the processed nesfatin-1 (expected size: ,9.5 kDa) was
detected in either rat or goldfish brain samples.
Nesfatin-1-like ir in the Hypothalamus
A sagittal view of the goldfish brain stained with nesfatin-1
antiserum, revealed a large number of ir cell bodies within the
goldfish hypothalamus (Figure 6A–F). A relatively high propor-
tion of these cell bodies were found within the nucleus anterior
tuberis (NAT) (Figure 6A, E). More caudally, many nesfatin-1-
like ir neurons were observed within the nucleus lateralis tuberis
(NLT). These fluorescent perikarya were found in the central
(NLTp) and lateral regions (NLTl) of the NLT (Figure 6B, F). All
immunoreactive cells within the brain were stained clearly with the
nuclear stain DAPI (Figure 6C, D). Immunohistochemical
analysis showed strong cytoplasmic staining and no nesfatin-1-
like ir was observed in nerve fibers. No staining was observed in
brain sections where primary antibody was omitted (Figure 6G,
Figure 2. Phylogenetic analysis of nucleobindin gene sequences. NUCB2A and NUCB2B (teleost only), and NUCB1 amino acid sequences.
Each node has a bootstrap value which was obtained for 500 replicates. GenBank Accession Numbers or Ensembl identification numbers are as
follows; Caenorhabditis elegans (NUCB1, NM_171763.3), Drosophila melanogaster (NUCB1, AAF49304.3), Rattus norvegicus (NUCB1, AAI00644.1), Mus
musculus (NUCB1, AAH72554.1; NUCB2, AAH10459.1), Homo sapiens (NUCB1, NP_006175.2; NUCB2, NP_005004.1), Takifugu rubripes (NUCB1,
ENSTRUP00000000823; NUCB2A, ENSTRUP00000044315; NUCB2B, ENSTRUP00000038477), Tetraodon nigroviridis (NUCB2A, ENSTNIP00000012254;
NUCB2B, ENSTNIP00000005671), Gasterosteus aculeatus (NUCB1, ENSGACP00000016912; NUCB2A, ENSGACP00000020611; NUCB2B, EN-
SGACP00000008999), Oryzias latipes (NUCB2A, ENSORLP00000008372; NUCB2B, ENSORLP00000001612), Danio rerio (NUCB1, NM_001045463.1;
NUCB2A, NM_201493.1; NUCB2B, NM_201479.1), Xenopus tropicalis, (NUCB2, AAH90107.1), Gallus gallus (NUCB2, NP_001006468.1), and Carassius
auratus (NUCB2A, HM065567.1).
doi:10.1371/journal.pone.0015201.g002
Nesfatin-1 Inhibits Feeding in Fish
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15201H). In order to confirm specificity of the anti-nesfatin-1 antibody,
which probes nesfatin-1 and the precursor NUCB2, a western blot
of goldfish whole brain tissue lysates was conducted.
Nesfatin-1-like ir in the J-loop
Longitudinal sections of the goldfish anterior intestine stained
for nesfatin-1-like ir within enteroendocrine like cells of the
intestinal villi (Figure 7A). Most of these cells were scattered deep
within the folds of the villi, however, some of the cells were
dispersed along the apical regions of the villi. Lightly stained
blebbed processes emanating from the enteroendocrine cells are
visible and appear to project towards the lumen (Figure 7A, C).
The nuclear stain, DAPI, stained clearly within the cell bodies of
nesfatin-1-like ir cells and non-ir cells (Figure 7B, C). No staining
was observed in sections in which only secondary antibody was
used (Figure 7D).
Effects of IP Injections of Nesfatin-1 on Food Intake of
Goldfish
A single IP injection of 50 ng/g BW (5.3 pmol/g BW)
gfnesfatin-1 reduced food intake maximally by 23% compared to
saline treated fish (P,0.01) (Figure 8A, B). Additionally, an
injection of 500 ng/g BW (53 pmol/g BW) gfnesfatin-1 produced
similar reductions in food intake with an 18% reduction compared
to controls (Figure 8B)( P ,0.05). Furthermore, lower doses (0.5
and 5 ng/g BW, 0.053 and 0.53 pmol/g BW, respectively) of
gfnesfatin-1 were ineffective in altering food intake during the
study period (Figure 8A).
Effects of ICV Injections of Nesfatin-1 on Food Intake of
Goldfish
ICV injections of synthetic gfnesfatin-1 produced enhanced
reductions in food intake. An ICV injection of 0.5 or 25 ng/g BW
(0.053 or 2.65 pmol/g BW, respectively) of gfnesfatin-1 reduced
food intake by 43, and 51%, respectively (P,0.05, one-way
ANOVA) (Figure 8C).
Discussion
We employed a multifaceted approach to characterize the
structure, distribution, and appetite regulatory effects of nesfatin-1
in non-mammalian vertebrates for the first time. The goldfish
NUCB2A mRNA sequence reported here is 1568 bp and encodes
a 23 amino acid signal peptide followed by a 476 amino acid
NUCB2A prohormone. Comparative analysis of the sequence we
obtained indicates that goldfish NUCB2 sequence belongs to a
subgroup of NUCB2 sequences in teleost fishes called NUCB2A.
The presence of duplicated NUCB2 genes in teleost fishes
Figure 3. Differential expression of NUCB2 mRNA in goldfish tissues. NUCB2 and beta-actin cDNA amplicon products from the tissues of
Carassius auratus by reverse transcriptase PCR (A). More precise quantitative data was obtained by using Real-Time Quantitative Reverse
Transcription PCR (B). The results were normalized to b-actin, which served as a control to verify the amount and quality of samples (n=5 fish).
doi:10.1371/journal.pone.0015201.g003
Nesfatin-1 Inhibits Feeding in Fish
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15201presumably arose through an independent tetraploidization
known as 3R (third round of genome duplication) [28,29]. A
wider phylogenetic analysis of NUCB2 sequences in several
teleosts shows strong clustering for 2 paralogous NUCB2 genes
(NUCB2A and NUCB2B). In addition, the proposed prohormone
convertase cleavage site (Lys-Arg) is ubiquitously conserved in
both paralogous NUCB2 genes, suggestive that the putative
nesfatin-1 peptide can be cleaved from the larger NUCB2
precursor. The complexity of the goldfish genome suggests that
an additional NUCB2B gene may exist. Furthermore, the
duplication of the NUCB2 gene suggests a potential for
redundancy and subspecialization possibly contributing to a more
complicated nesfatin-1 system in fishes than in mammals.
Interestingly, NUCB1 in teleosts is also highly conserved and
retains the proposed prohormone convertase cleavage site.
However, to date no evidence exists for NUCB1 in the regulation
of food intake and energy expenditure.
Oh-I et al. (2006) initially proposed the post-translational
processing of NUCB2 through specific cleavage sites by prohor-
mone convertases (PCs). These cleavage sites which consist of the
basic amino acid pairs, Lys-Arg and/or Arg-Arg remain conserved
in goldfish. It is well known that PC1/3 and PC2 are the major
PCs involved in prohormone processing. In addition, previous
studies have described the presence of PC1/3 and PC2 in early
Figure 4. Feeding status affects the expression of NUCB2 mRNA within the hypothalamus and liver of goldfish. Pre- and post-prandial
changes in the expression of NUCB2 mRNA in the (A) hypothalamus and (B) liver of goldfish. The mRNA expression of nesfatin was normalized to b-
actin and represented relative to the 23 hour scheduled feeding time group. Asterisks represent significant differences between groups at the same
time point. Food deprivation decreased expression of NUCB2 mRNA in the goldfish hypothalamus (C) and increased its expression in the liver (D).
Three and 7 day NUCB2 mRNA expression is represented as the normalized percentage of the NUCB2 mRNA expression in the 3 day food-deprived
fish. One-way ANOVA, Newman-Keuls Multiple Comparison Test. Asterisks represent significant differences between groups at the same time point.
*P ,0.05, ** P,0.01, *** P,0.001. (n=6 fish/group).
doi:10.1371/journal.pone.0015201.g004
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convertase processing of NUCB2 is expected to yield nesfatin-1,
nesfatin-2, and nesfatin-3, similar to what has been proposed in
mammals. However, in our Western blot analyses, we did not see
the expected 9.5 kDa band representing nesfatin-1 in goldfish or
rat brain. The commercially available antibody used in this study
is the most widely reported in the nesfatin-1 literature. To date,
none of these reports were able to show endogenous, fully
processed nesfatin-1 using the Western blot technique in any
species. It is possible that processed nesfatin-1 levels are below the
detectable range. In addition, previous studies have speculated
that NUCB2 is only processed upon secretion into the circulation
to generate the 9.5 kDa peptide [9]. Given that the antibody used
here detects the precursor form of the peptide, the immunoreac-
tivity we report represents the precursor as well as the processed
peptides. In goldfish, the predicted nesfatin-1 and 2 are highly
conserved and are 82 and 81 amino acids long, respectively.
Nesfatin-3 is longer in goldfish (309 amino acids) than in rat (231
amino acids). In addition, the mid-segment of nesfatin-1 is well
conserved among the vertebrates examined here. According to
Shimizu et al., (2009) the mid-segment of nesfatin-1 (24–53) is the
bioactive appetite inhibitory segment. The identification of a
highly conserved NUCB2 and nesfatin-1 in lower vertebrates lays
the foundation for further studies on this novel hormone.
In rats, NUCB2 is found in many regions of the brain, including
the paraventricular nucleus (PVN), arcuate nucleus (ARC),
supraoptic nucleus (SON), and in the lateral hypothalamic area
(LHA), and the zona incerta [1]. In addition, nesfatin-1-ir has been
detected in the nucleus of the solitary tract (NTS) and dorsal
nucleus of the vagus nerve [1,2]. Furthermore, there is increasing
evidence for the presence of nesfatin-1 in peripheral tissues.
Pronesfatin is found in the oxyntic cells of the fundic mucosa [9]
and in the beta cells of the Islets of Langerhans [10,11]. The
current study extends these findings by describing the tissue
distribution of nesfatin-1 within a non-mammalian vertebrate
species. Goldfish NUCB2 is expressed in various tissues. The
highest expression was found in the liver, pituitary, olfactory bulbs,
hypothalamus, telencephalon, gall bladder, and adipose tissue of
goldfish. Providing further support, our immunohistochemical
studies show the presence of nesfatin-1-like ir within the
hypothalamus and preoptic areas of the goldfish brain. Nesfatin-
1-like ir was detected in enteroendocrine like cells lining the J-loop,
a structure homologous to the mammalian stomach. These
observations expand the mRNA expression studies by confirming
the presence of nesfatin-1-like ir within the anterior intestine.
These results from a distantly related lower vertebrate highlights
the growing evidence in support of a role for nesfatin-1 as a novel
brain-gut regulatory peptide.
The nucleus lateralis tuberis (NLT) of goldfish is considered as a
teleostean homologue to the mammalian arcuate nucleus [30,31].
The largest number of nesfatin-1-like ir cell bodies were found in
the NLT of goldfish. Interestingly, the NLT neurons which stain
for nesfatin-1-like ir are also known to innervate the goldfish
pituitary [32,33]. Unlike in tetrapods, which release neurohor-
mones through the classical hypothalamic-pituitary portal system,
teleost fish have processes that originate from the neurohypophysis
Figure 5. One-day food deprivation reduces serum nesfatin-1
levels in goldfish. Elevated serum nesfatin-1 levels can be detected
up to 1 hour post-feeding but is reduced 3 hours post-feeding (A).
Nesfatin-1 ELISA standard curve shows strong cross reactivity with
goldfish nesfatin-1 over a range of 1–100 ng/ml (B). Western blot
analysis confirmed the specificity of polyclonal pronesfatin antibody (C).
Rodent and goldfish pronesfatin (NUCB2) were detected at their
predicted molecular weights, ,50 and ,59 kDa, respectively, b-tubulin
was added as a loading control and detected in both rat and goldfish
tissues. No bands representing processed nesfatin-1 (,9.5 kDa) was
found in both rat and goldfish brain.
doi:10.1371/journal.pone.0015201.g005
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and intermediate lobes [34]. Furthermore, the abundance of
NUCB2 observed in the pituitary is suggestive of a role for
nesfatin-1 in the regulation of the hypothalamo-pituitary axis. To
date, many other well established neuropeptides with mammalian
orthologues have been characterized within the NLT of the
goldfish brain. Immunoreactive NPY and AgRP neurons as well as
in situ hybridized preprocholecystokinin and preprogalanin
perikarya have been described in the NLT [35–37]. In addition,
cell bodies for appetite-suppressing POMC and the melanocortin
4 receptor (MC-4R) ir cell bodies have been described within the
NLT [38]. The localization of nesfatin-1-like ir neurons in the
NLT suggest possible interactions of nesfatin-1 with other peptides
in regulating food intake. Current research in mammals suggests
that nesfatin-1 may act through a central oxytocin system
originating from the oxytocin neurons in the PVN which exert
Figure 6. Characterization of nesfatin-1 like immunoreactivity within the goldfish hypothalamus. Immunohistochemical staining of
goldfish hypothalamus for nesfatin-1-like immuunoreactivity (A, B; red), DAPI (C, D; nuclei; blue) and the merged image of nesfatin-1 and DAPI is
shown in E and F. Representative cells that are immunopositive for nesfatin-1 in the NAT (A; open arrows) or in the NLTp (B; solid arrow) or in the NLTl
(B; solid arrowhead) are shown. Figures G and H represents a no-primary antibody negative control, which was labeled only with secondary
antibodies. Representative images were taken of 30 sections from 6 separate goldfish hypothalami.
doi:10.1371/journal.pone.0015201.g006
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ally, nesfatin-1 may act either in series or independently through
the central melanocortin system by directly acting upon POMC
neurons in the ARC to affect oxytocin neurons in the
paraventricular nucleus (PVN) [16]. Whether or not the central
physiological effects of nesfatin-1 are mediated in a similar manner
as suggested by the distribution pattern in the goldfish hypothal-
amus remains to be determined.
NUCB2 expression has been shown to selectively decrease in
the PVN under starved conditions, while re-feeding returned
NUCB2 back to control levels [1]. Our findings confirm and
extend these findings in non-mammalian vertebrates. Goldfish
NUCB2 mRNA levels remained statistically indistinguishable in
the hypothalamus until after feeding. At 1 hour and 3 hours post-
feeding, the levels of NUCB2 increased by ,2-fold compared to
unfed controls. In addition, an ,3 and 2-fold difference in
NUCB2 mRNA was observed in the hypothalamus of fish
deprived of food for 3 or 7 days, respectively. Furthermore, a 2-
fold increase was detected in the hypothalamus of animals re-fed
after a 7 day food deprivation, compared to ad libitum fed animals.
Previous studies in rats have shown that circulating levels of
nesfatin-1 decrease during fasting and increase significantly after a
meal [15]. In addition, Stengel et al., (2009) observed a down-
regulation of NUCB2 mRNA in gastric endocrine cells during
fasting and increases in NUCB2 mRNA in the stomach and brain
of fed rodents. Since the changes observed in NUCB2 mRNA are
not indicative of the synthesis or release of the peptide, we tested
goldfish blood serum during different nutritional challenges to
examine the levels of nesfatin-1 in circulation. In accordance with
our mRNA expression data we also observed significant decreases
in the levels of serum nesfatin-1 in 24 h food-deprived goldfish
compared to ad libitum fed controls. Interestingly, NUCB2 mRNA
in the liver was elevated during food deprivation. During food
deprivation, liver gluconeogenesis acts as a primary source of
glucose to facilitate the restoration of normoglycemia [40–42].
The significant upregulation of liver NUCB2 mRNA is possibly
indicating a direct role for nesfatin-1 or other NUCB2 encoded
peptides in liver physiology during food deprivation. One may
speculate that this increase in liver NUCB2 suggests a potential
tissue specific local role for NUCB2 peptides in the regulation of
cellular gluconeogenic process in catabolic states. Further studies
are warranted to determine the role of NUCB2 and nesfatin-1 on
liver function, specifically in fed and fasted conditions.
The relative abundance of NUCB2 mRNAexpression in goldfish
adipose tissues may also be of particular importance. The role of
adipose tissue in integrating metabolic activity and energy balance
via adipokines has been thoroughly established [43]. Recent reports
suggest that nesfatin-1 may play a role in adipocyte regulation in
mice [44]. Circulating levels of nesfatin-1 and nesfatin-1 protein
expression in adipose tissue is significantly elevated in high-fat-fed
mice [44]. In addition, intracellular nesfatin-1 levels increase when
adipose tissue is incubated in inflammatory cytokines [44].
Furthermore, the incubation of nesfatin-1 significantly increases
the differentiation of preadipocytes into adipocytes [44]. It is
possible that adipose tissueis a majorsourceof circulatingnesfatin-1
in goldfish and that nesfatin-1 has a role in adipose metabolism.
However, the above observations from mammals cannot be applied
to fish as they are poikilothermic organisms with different metabolic
strategies. Whether, nesfatin-1 has similar conserved roles in teleost
fishes is of great interest and should be investigated further.
Our in vivo studies in goldfish provide the first functional
evidence for the appetite regulatory effects of nesfatin-1 in a non-
mammalian vertebrate. Intraperitoneal injections of nesfatin-1 at a
dose of 50 ng/g BW inhibited food intake by approximately 20%
Figure 7. Nesfatin-1 like immunoreactivity is also present within the goldfish gut. Nesfatin-1-like immunoreactivity found within
enteroendocrine cells of the goldfish gut. Immunohistochemical localization shows nesfatin-1-like immunoreactive cells (arrows) in the intestinal villi
of the gut (A). The nuclear stain DAPI (B) and merged images (C) show nesfatin-1-like immunoreactive cells along the base of the intestinal villi (solid
arrow). The inset in C shows a representative nesfatin-1-like immunoreactive cell under high magnification (100x). A negative control where no
primary, but only secondary antibody showed no staining (D). Representative images were taken of 18 sections from 6 separate goldfish guts.
doi:10.1371/journal.pone.0015201.g007
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food intake has been observed with peripheral injections of
nesfatin-1 over the first hour [1]. When nesfatin-1 was injected
centrally at a dose as low as 0.5 ng/g BW we observed a striking
43% reduction in food intake over one hour. Although nesfatin-1
injected into the periphery has been shown to cross the blood brain
barrier [45,46] to cause the anorectic effect, Stengel et al., (2009)
reported that peripheral injections of nesfatin-1 in mice reduced
food intake, but the results were more readily observed through
central injections. Peripherally administered nesfatin-1 might elicit
its anorectic effects by acting on peripheral mechanisms such as gut
motility or by acting at the appetite regulatory neurons after
entering the brain. Although further studies are required to
elucidate the mechanisms of actions and interactions of nesfatin-1
in the goldfish brain, our results clearly indicate an anorexigenic
effect for the native form of nesfatin-1 in goldfish.
Together, our results provide the first molecular and functional
evidence for the wide presence and distribution of NUCB2 and
anorectic effects of nesfatin-1 in non-mammalian vertebrates. This
report furthers our current understanding of nesfatin-1 as a novel,
meal responsive anorexigenic and metabolic peptide (Figure 9)
with an evolutionarily conserved structure and function. Whether
nesfatin-1 or other nesfatin peptides encoded in NUCB2 have
biological actions other than the regulation of feeding has to be
determined. The receptor(s) that mediates the actions of nesfatin-1
and the mechanisms of actions of nesfatin-1 remain unknown. The
results of our studies set the stage for several lines of further
investigations to better understand the functions and mechanisms
of actions of NUCB2 and nesfatin-1, novel, endogenous
biologically active peptides in vertebrates.
Figure 8. Effects of goldfish (gf) nesfatin-1 administration on
food intake over 1 h post-injection. Effects of intraperitoneal (IP)
injections of relatively low doses of gfnesfatin-1 (0.5, 5, and 50 ng/g
body weight [BW]) (A). Effects of IP injections of relatively high doses of
gfnesfatin-1 (50, and 500 ng/g BW) (B). Effects of intracerebroventricular
(ICV) injections of gfnesfatin-1 on food intake over 1 hour (C). A 0.5 and
25 ng/g BW ICV injection of the gfnesfatin-1 significantly reduced food
intake over one hour by ,43 and 50%, respectively. One-way ANOVA,
Newman-Keuls Multiple Comparison Test. ** P,0.01, * P,0.05. (n=6
fish/group).
doi:10.1371/journal.pone.0015201.g008
Figure 9. A summary on the distribution and functions of
nesfatin-1 based on our findings in goldfish. NUCB2/nesfatin-1 is
abundantly expressed in the brain, liver and gut. NUCB2 mRNA was
upregulated in the brain of fed fish and in the liver of fasted fish, while
NUCB2 mRNA was down-regulated in the brain of fasted fish and in the
liver of fed fish (solid arrows). Although the major tissue source of
circulating nesfatin-1 is currently unknown, we propose that nesfatin-1
is released in a meal responsive manner from several tissues, including
the brain, liver and gut to inhibit feeding in fish via central and
peripheral actions. Nesfatin-1 seems to have direct effects on the liver,
possibly in regulating the metabolic processes, especially during food-
deprivation (eg: gluconeogenesis?). Solid lines indicate direct known
effects while dashed arrows indicate potential relationships.
doi:10.1371/journal.pone.0015201.g009
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Table S1 Primers used for reverse transcription, 59 and 39 rapid
amplification of cDNA ends, and quantitative real-time PCR of
NUCB2 mRNA from the tissues of goldfish.
(TIF)
Figure S1 Nucleotide sequence of goldfish NUCB2 mRNA.
Nesfatin-1 peptide region is underlined in black, nesfatin-2 is
underlined in gray, and nesfatin-3 is underlined with dotted lines.
The predicted cleavage sites required for processing are boxed.
(TIF)
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